InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（27 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
27
T+90 胜率
68%
T+90 平均收益
+15.0%
基于 28 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Adair Jason, Chief Business Officer. Director active across 1 company, notably Liquidia Corp. In total, 65 disclosures have been recorded. Split: 0 buy · 27 sells. Total volume traded: €2.1m. Activity tracked since 6 July 2023. The latest transaction was disclosed on 13 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
申报65 总计
2,475 股Common StockSEC:0001104659-26-083618:1
3,869 股Common StockSEC:0001104659-26-083618:2
562 股@ US$71.39Common StockSEC:0001104659-26-083618:3
7,301 股@ US$71.52Common StockSEC:0001104659-26-083618:4
3,907 股Common StockSEC:0001104659-26-083618:0
688 股@ US$41.650.0004% mcap1.5% 占其流量Common StockSEC:0001104659-26-051571:0
3,906 股Common StockSEC:0001104659-26-043271:0
2,474 股Common StockSEC:0001104659-26-043271:1
3,868 股Common StockSEC:0001104659-26-043271:2
7,301 股@ US$38.370.0043% mcap15.1% 占其流量Common StockSEC:0001104659-26-043271:3
1,562 股Common StockSEC:0001104659-26-022895:0
688 股@ US$41.651.3% 占其流量Common StockSEC:0001104659-26-007428:0
27,683 股0Common StockSEC:0001104659-26-005490:0
3,906 股Common StockSEC:0001104659-26-003371:0
2,474 股Common StockSEC:0001104659-26-003371:1
15,474 股Common StockSEC:0001104659-26-003371:2
13,548 股@ US$37.4327.6% 占其流量Common StockSEC:0001104659-26-003371:3
1,563 股Common StockSEC:0001104659-25-117734:0
693 股@ US$32.191.2% 占其流量Common StockSEC:0001104659-25-117734:1
35,291 股@ US$5.899.9% 占其流量Common StockSEC:0001104659-25-114634:0
692 股@ US$22.930.8% 占其流量Common StockSEC:0001104659-25-103752:0
3,906 股Common StockSEC:0001104659-25-099745:0
3,906 股Common StockSEC:0001104659-25-086437:0
26,057 股@ US$27.856439.4% 占其流量Common StockSEC:0001104659-25-086437:1
1,562 股Common StockSEC:0001104659-25-086437:2
65 条申报中的 25 条
About Adair Jason
Adair Jason is Chief Business Officer at Liquidia Corp (XNAS). He has 60 filings in total, and across the recent sampled filings, sales amount to EUR 1,648,430 between 2023-07-07 and 2026-04-29, with transactions mainly related to option exercises.
